None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants aged greater than 18 years will be included in the study. 2. Patients indicated for single-stage implant placement with early loading. 3. Adequate bone volume for implant placement without the need for augmentation 4. Willingness to participate and comply with follow-up visits
Exclusion criteria
Exclusion criteria: 1. Smokers or tobacco users. 2. Antibiotic or probiotic use within the last 3 months. 3. Pregnant or lactating women. 4. Known allergy to chlorhexidine or probiotic (Self-Reported). 5. Systemic diseases or conditions such as metabolic diseases, bone and haematological diseases, immunodeficiency, uncontrolled diabetes mellitus, kidney failure, tumor or radiation in the head and neck area or any other disease contraindicating implant placement. 6. Patients unwilling to complete the treatment protocol. 7. Patient with a history of allergic tendencies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbial Metagenomic Analysis i.Relative abundance of microbiota ii.Microbial diversity iii.Dysbiosis index Clinical Evaluation including BOP, mPI, PD Patient-Reported Outcome Measures (PROMs) Timepoint: baseline,7 days,3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical Parameters IL-1Beta,MMP 8 Radiographic Bone Levels Incidence of peri-implant mucositis Timepoint: baseline,7 days,3 months and 6 months | — |
Countries
India
Contacts
Dr Harvansh Singh Judge Institute of Dental Sciences and Hospital, Chandigarh